Evaluation of the Protective Efficacy of Swine Influenza Bivalent
Inactivated Vaccine Against Epidemic Strains of H1N1 and H3N2 Swine
Influenza Viruses
The protective effect of swine influenza bivalent inactivated vaccine (H1N1 AH
strain+H3N2 JS strain) on the epidemic strain of swine influenza virus was
evaluated in the present study. Healthy susceptible piglets aged 4 to 5 weeks
were immunized twice (with an interval of 2 weeks). Two weeks
after the booster immunization, blood samples were collected and tested
for HI antibody levels using vaccine strains SW/AH/17, SW/JS/17, as well as
epidemic strains SW/GD/21 and SW/SD/22. Then, two weeks after
the booster immunization, epidemic strains SW/GD/21 and SW/SD/22 were
used for challenge. After challenge, clinical symptoms were observed daily, body
temperatures were measured, and nasal swabs were collected for 3-5 days to
detect detoxification. On the 5th day, all experimental animals were autopsied
to observe the degree of lung injury. The results showed that on the 14th day
after the booster immunization, all piglets in the immunized group produced high
levels of antibodies against H1 and H3 subtypes, but the antibody levels
detected against the epidemic strains were 1-2 titer lower than those of the
vaccine strains. After challenge with the epidemic strains, except for one
piglet in the SW/GD/21 challenge group with a body temperature exceeding 40.2℃
and detoxification detected, no significant respiratory symptoms were observed
in the remaining immunized piglets, and no detoxification was detected. No
typical pathological damage was observed in the lungs. Compared with the
unimmunized control group, the immunized piglets after challenge with the
epidemic strains showed reduced respiratory symptoms caused by swine influenza
virus infection, blocked continuous detoxification to the outside world, and
significantly reduced pathological damage in the lungs. The study results showed
that the swine influenza bivalent inactivated vaccine (H1N1 AH strain + H3N2 JS
strain) can provide good protection against both H1N1 and H3N2 epidemic strains.
To Cite This Article:
shen C,
Chen C,Tian C, Zhang Y, Yan X, Lu W, Xu C, Shi Y and Su W,
2025. Evaluation of the protective efficacy of swine influenza bivalent
inactivated vaccine against epidemic strains of H1N1 and H3N2 swine influenza
viruses. Pak Vet J. http://dx.doi.org/10.29261/pakvetj/2025.299